Meeting
2023 ASCO Annual Meeting
Effects of yoga vs placebo on inflammation among cancer survivors: A nationwide multicenter phase III randomized controlled trial (RCT).
Authors
Po-Ju Lin
Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
Po-Ju Lin , Hongying Sun , Umang Gada , Richard Francis Dunne , Ian Kleckner , Evelyn Arana , Alisha Chakrabarti , Stephen Rajan Samuel , Charles Stewart Kamen , Janos Molnar , John Scott Maul , Judith O. Hopkins , Karen Michelle Mustian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
NCT02613364
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12111)
DOI
10.1200/JCO.2023.41.16_suppl.12111
Abstract #
12111
Poster Bd #
479
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Effects of yoga, cognitive behavioral therapy, and a behavioral placebo on sleep: A nationwide multicenter phase III RCT in cancer survivors.
First Author: Po-Ju Lin
Poster
2023 ASCO Annual Meeting
Yoga vs. behavioral placebo for fatigue and quality of life among older cancer survivors.
First Author: Evelyn Arana
Poster
2022 ASCO Annual Meeting
Sacubitril-valsartan improves longitudinal strain and ejection fraction in preclinical models treated with anthracyclines through NLRP3, MyD88 pathways resulting in a reduction of myocardial IL-1β, IL-6, TNF-α and growth factors.
First Author: Nicola Maurea
Poster
2022 ASCO Annual Meeting
Dapagliflozin associated to sacubitril/valsartan and relationship with cardioprotection in human cardiac cells exposed to doxorubicin and HER2-blocking agents through MyD88, NLRP3 mediated pathways.
First Author: Nicola Maurea